Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine

Conclusions and Clinical Relevance: This is the first application of a LFQ‐PRM workflow to identify and validate ovarian cancer‐specific biomarkers in patient urine samples.This article is protected by copyright. All rights reserved

Source: Proteomics. Clinical Applications - January 1, 2018 Category: Biochemistry Authors: Jarrod J. Sandow, Adam Rainczuk, Giuseppe Infusini, Ming Makanji, Maree Bilandzic, Amy L. Wilson, Nicole Fairweather, Peter G. Stanton, Daniel Garama, Daniel Gough, Thomas W. Jobling, Andrew I. Webb, Andrew N. Stephens Tags: RESEARCH ARTICLE Source Type: research